This division of AAM educates patients about the safety and effectiveness of biosimilars, according to a May 24 release. Member organizations include manufacturers developing biosimilar products for the U.S. market.
In his role at ASCA, Mr. Selde represented ASCs before both federal agencies and Congress.
Mr. Selde attended Creighton University School of Law in Omaha, Neb., and received his BA from New York City-based Fordham University.
